Sponsor pipeline

Lynk Pharmaceuticals Co., Ltd clinical trial pipeline

Get alerts when Lynk Pharmaceuticals Co., Ltd's trials change

2 active trials 1 recruiting 2 Phase 3 2 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

Active trials by phase

Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07237568 A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis Ankylosing Spondylitis Recruiting 2025-11-20
NCT06276998 A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA) Rheumatoid Arthritis Active, Not Recruiting 2026-01-14

Disease areas by active trials

Ankylosing Spondylitis (1) · Rheumatoid Arthritis (1)

Get alerts when Lynk Pharmaceuticals Co., Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free